Financials
Financial year 2025
COVEFAR from Gent, company number BE0461537678, closed financial year 2025 with a result of € 116,333 after tax. For that financial year COVEFAR recorded a gross margin of € 158,723 and equity of € 897,517. Compared with financial year 2024, the result moved from € 132,341 to € 116,333. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 897,517
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 116,333
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 35,771
▲ € 30,425 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 823,149.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 23
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 40,347
▲ 18% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 37,923 | € 72,608 | € 132,993 | € 158,723 | ▲ 19% |
| Profit after taxes | € 20,744 | € 57,011 | € 132,341 | € 116,333 | ▼ 12% |
| Equity | € 595,216 | € 650,561 | € 781,184 | € 897,517 | ▲ 15% |
| Total debts | € 616,264 | € 630,461 | € 420,116 | € 181,220 | ▼ 57% |
| Cash | € 10,995 | € 12,418 | € 5,346 | € 35,771 | ▲ € 30,425 |
| Retained profit | € 520,848 | € 576,193 | € 706,816 | € 823,149 | ▲ 16% |
| Dividend | € 1,600 | € 1,666 | € 1,718 | € 0 | ▼ 100% |
| Balance sheet total | € 1,211,480 | € 1,281,021 | € 1,201,300 | € 1,078,737 | ▼ 10% |
Key figures of COVEFAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to COVEFAR?
What happened at COVEFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Luc Coussens stepped down as director. NBB
- Nicole Van Der Vennet stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 116,333 (▼ 12% vs 2024). Source: NBB ↗
- Luc Coussens became a director. NBB
- Nicole Van Der Vennet became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 20,744 profit in 2022 to € 116,333 profit in 2025.
Paid € 136,961 in corporate taxes since 2022.
Best year ever: 2024, with € 132,341 profit.
Paid out € 4,984 in dividends to the owners in total.
Management
It owns 99.8% of Apotheek Van der Vennet NV itself.
Directors
According to the 2025 annual accounts
Luc Coussens
Director
since 2009 · until 2027
Nicole Van Der Vennet
Director
since 2009 · until 2027
Establishments
Establishment units
Physical locations of this company
Langestraat 126
9050 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0461.537.678
- VAT number
- BE 0461.537.678
- Registered office
- Langestraat 126, 9050 Gent
- Names & denominations
- COVEFAR
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 September 1997
- Peppol
- Active · Active since 23 Sept 2025
- Activities · NACE
Diverse ondersteunende activiteiten ten behoeve van voorzieningen
Beheer van overig onroerend goed
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.